The rising prevalence in GLP-1 agonists for diabetes has sparked a discussion about delivery routes : transdermal systems versus pills . Usually , GLP-1 drugs were solely available in oral form, but the https://kallumuddu202401.blogdal.com/41366324/glp-1-skin-applications-vs-pills-is-suitable-for-individuals